EUVIMEDEUVIMED entdecken
Übersichtsarbeit

State-of-the-Art Review: Persistent Enterococcal Bacteremia

Ralph Rogers, Louis B Rice

Clinical Infectious Diseases · 25.01.2024 · 78 (1) · e1-e11

DOI: 10.1093/cid/ciad612 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, online erschienen am 29.11.2023. Verfasst von Ralph Rogers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Bacteremia, Bacterial Infections, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Persistent enterococcal bacteremia is a commonly encountered and morbid syndrome without a strong evidence base for optimal management practices. Here we highlight reports on the epidemiology of enterococcal bacteremia to better describe and define persistent enterococcal bacteremia, discuss factors specific to Enterococcus species that may contribute to persistent infections, and describe a measured approach to diagnostic and therapeutic strategies for patients with these frequently complicated infections. The diagnosis of persistent enterococcal bacteremia is typically clinically evident in the setting of repeatedly positive blood culture results; instead, the challenge is to determine in an accurate, cost-effective, and minimally invasive manner whether any underlying nidus of infection (eg, endocarditis or undrained abscess) is present and contributing to the persistent bacteremia. Clinical outcomes for patients with persistent enterococcal bacteremia remain suboptimal. Beyond addressing host immune status if relevant and pursuing source control for all patients, management decisions primarily involve the selection of the proper antimicrobial agent(s). Options for antimicrobial therapy are often limited in the setting of intrinsic and acquired antimicrobial resistance among enterococcal clinical isolates. The synergistic benefit of combination antimicrobial therapy has been demonstrated for enterococcal endocarditis, but it is not clear at present whether a similar approach will provide any clinical benefit to some or all patients with persistent enterococcal bacteremia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaBacterial InfectionsGram-Positive Bacterial InfectionsHumansAnti-Bacterial Agents

Stichwörter der Autor:innen

bacteremiadurationenterococcuspersistencereview

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases and Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Zitieren

APA

Rogers, R., & Rice, L. B. (2024). State-of-the-Art Review: Persistent Enterococcal Bacteremia. Clinical Infectious Diseases, 78(1), e1-e11. https://doi.org/10.1093/cid/ciad612

Vancouver

Rogers R, Rice LB. State-of-the-Art Review: Persistent Enterococcal Bacteremia. Clinical Infectious Diseases. 2024;78(1):e1-e11. doi:10.1093/cid/ciad612

BibTeX
@article{Rogers2024,
  author = {Rogers, Ralph and Rice, Louis B},
  title = {State-of-the-Art Review: Persistent Enterococcal Bacteremia},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {1},
  pages = {e1--e11},
  doi = {10.1093/cid/ciad612}
}
Kostenlos starten →